Cargando…
Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development
BACKGROUND: Staphylococcus aureus is a Gram-positive bacterium that causes severe illnesses in the human population. The capacity of S. aureus strains to form biofilms on biotic and abiotic surfaces creates serious problems for treatment of hospital infections and has stimulated efforts to develop n...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944129/ https://www.ncbi.nlm.nih.gov/pubmed/29785216 http://dx.doi.org/10.2174/1874285801812010094 |
_version_ | 1783321767763247104 |
---|---|
author | Belyi, Yury Rybolovlev, Ivan Polyakov, Nikita Chernikova, Alena Tabakova, Irina Gintsburg, Alexandre |
author_facet | Belyi, Yury Rybolovlev, Ivan Polyakov, Nikita Chernikova, Alena Tabakova, Irina Gintsburg, Alexandre |
author_sort | Belyi, Yury |
collection | PubMed |
description | BACKGROUND: Staphylococcus aureus is a Gram-positive bacterium that causes severe illnesses in the human population. The capacity of S. aureus strains to form biofilms on biotic and abiotic surfaces creates serious problems for treatment of hospital infections and has stimulated efforts to develop new means of specific protection or immunotherapy. MATERIAL AND METHODS: We found that rabbit serum raised against crude concentrated S. aureus liquid culture significantly decreased the development of staphylococcal biofilm in vitro. To discover the corresponding staphylococcal antigen, we used mass-spectrometry and molecular cloning and identified three major immunodominant proteins. They included α-haemolysin, serine proteinase SplB and S. aureus surface protein G, known as adhesin SasG. RESULTS: Although according to literature data, all these proteins represent virulence factors of S. aureus and play diverse and important roles in the pathogenesis of staphylococcal diseases, only SasG can be directly implicated into the biofilm formation because of its surface location on a staphylococcal cell. Indeed, rabbit serum directed against purified recombinant SasG, similar to serum against crude staphylococcal liquid culture, prevented the formation of a biofilm. CONCLUSION: SasG can be considered as a target in an anti-biofilm drug development and a component of the vaccine or immunotherapeutic preparations directed against staphylococcal infections in humans. |
format | Online Article Text |
id | pubmed-5944129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Bentham Open |
record_format | MEDLINE/PubMed |
spelling | pubmed-59441292018-05-21 Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development Belyi, Yury Rybolovlev, Ivan Polyakov, Nikita Chernikova, Alena Tabakova, Irina Gintsburg, Alexandre Open Microbiol J Microbiology BACKGROUND: Staphylococcus aureus is a Gram-positive bacterium that causes severe illnesses in the human population. The capacity of S. aureus strains to form biofilms on biotic and abiotic surfaces creates serious problems for treatment of hospital infections and has stimulated efforts to develop new means of specific protection or immunotherapy. MATERIAL AND METHODS: We found that rabbit serum raised against crude concentrated S. aureus liquid culture significantly decreased the development of staphylococcal biofilm in vitro. To discover the corresponding staphylococcal antigen, we used mass-spectrometry and molecular cloning and identified three major immunodominant proteins. They included α-haemolysin, serine proteinase SplB and S. aureus surface protein G, known as adhesin SasG. RESULTS: Although according to literature data, all these proteins represent virulence factors of S. aureus and play diverse and important roles in the pathogenesis of staphylococcal diseases, only SasG can be directly implicated into the biofilm formation because of its surface location on a staphylococcal cell. Indeed, rabbit serum directed against purified recombinant SasG, similar to serum against crude staphylococcal liquid culture, prevented the formation of a biofilm. CONCLUSION: SasG can be considered as a target in an anti-biofilm drug development and a component of the vaccine or immunotherapeutic preparations directed against staphylococcal infections in humans. Bentham Open 2018-04-30 /pmc/articles/PMC5944129/ /pubmed/29785216 http://dx.doi.org/10.2174/1874285801812010094 Text en © 2018 Belyi et al. https://creativecommons.org/licenses/by/4.0/legalcode This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Microbiology Belyi, Yury Rybolovlev, Ivan Polyakov, Nikita Chernikova, Alena Tabakova, Irina Gintsburg, Alexandre Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development |
title |
Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development |
title_full |
Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development |
title_fullStr |
Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development |
title_full_unstemmed |
Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development |
title_short |
Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development |
title_sort | staphylococcus aureus surface protein g is an immunodominant protein and a possible target in an anti-biofilm drug development |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944129/ https://www.ncbi.nlm.nih.gov/pubmed/29785216 http://dx.doi.org/10.2174/1874285801812010094 |
work_keys_str_mv | AT belyiyury staphylococcusaureussurfaceproteingisanimmunodominantproteinandapossibletargetinanantibiofilmdrugdevelopment AT rybolovlevivan staphylococcusaureussurfaceproteingisanimmunodominantproteinandapossibletargetinanantibiofilmdrugdevelopment AT polyakovnikita staphylococcusaureussurfaceproteingisanimmunodominantproteinandapossibletargetinanantibiofilmdrugdevelopment AT chernikovaalena staphylococcusaureussurfaceproteingisanimmunodominantproteinandapossibletargetinanantibiofilmdrugdevelopment AT tabakovairina staphylococcusaureussurfaceproteingisanimmunodominantproteinandapossibletargetinanantibiofilmdrugdevelopment AT gintsburgalexandre staphylococcusaureussurfaceproteingisanimmunodominantproteinandapossibletargetinanantibiofilmdrugdevelopment |